AstraZeneca Takes Personalized Approach To Cell Therapy With Neogene Buy

Pays $200m Upfront

 
• By Kevin Grogan
  
Galbraith Susan
Susan Galbraith • Source: AstraZeneca

More from Deals

More from Business